readthroughSign in
CompanyMNKDNasdaqDanbury, CT

Mannkind Corporation

MannKind develops drug-device combination therapies for cardiometabolic and orphan lung diseases, including treatments for diabetes, pulmonary hypertension, and fluid overload in heart failure and chronic kidney disease.

8-KNov 17Latest SEC filing
Nov 10Latest story